Tirzepatide

Experience the power of the first dual-target GIP and GLP-1 receptor agonist. Tirzepatide works smarter to dramatically reduce appetite, manage blood sugar, and promote significant weight loss. See the difference a true breakthrough in metabolic science can make.

Tirzepatide as a compound is FDA approved.

Dosing & Administration (DO NOT USE ON HUMANS)

Standard dosing ACCORDING TO THE FDA:

• Week 1-4: 2.5mg
• Week 5-8: 5mg
• Week 9-12: 7.5mg
• Week 13-16: 10mg
• Week 17-20: 12.5mg
• Week 21+: 15mg

Start with 2.5mg to minimize unwanted side effects such as nausea and titrate up only if current dose is tolerable and additional weight loss is needed.

Tirzepatide should be administered by a sub-q injection weekly.